A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma
Clinical trial NCT04624178 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04624178
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-05
- Primary completion
- 2025-11-17
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.